Technology | May 26, 2009

Mentice Offers VIST Enhanced Carotid, Coronary 7.7 Training Modules


The new and enhanced VIST Enhanced Carotid and Coronary 7.7 training modules, from Mentice, feature vital signs, complications, medication management and measurement functionality enhance to create clinical realism and elevate the educational value of simulation training. The system includes new patient cases, including chronic total occlusion and transradial access. The company said these cases challenge the learner to modify previously acquired skills to meet new procedural objectives. ?? The system offers vital signs recognition and response. ECG signals are derived from a model that recognizes a lack of oxygen supply to the heart. Any action that reduces oxygen supply will create changes in the ECG read out, requiring a trainee response. A select number of cases present complications that will occur as a result of trainee actions. For example, inserting a catheter too deeply into an ostium could result in spasm. Other complications are dissection, bradycardia and hypotension. Medication administration is now included to manage the complications the trainees encounter. Multiple cognitive decisions are required in this functionality, such as what medication, how much and how often. New measurement functionality allows the trainee to measure thing such as the diameter and length of lesions and reference vessels.

 


Related Content

News | Cath Lab

December 20, 2023 — Jason R. McCarthy, Ph.D., associate professor of biomedical research and translational medicine and ...

Home December 20, 2023
Home
News | Cath Lab

October 26, 2023 — Royal Philips, a global leader in health technology, announced the latest results demonstrating the ...

Home October 26, 2023
Home
News | Cath Lab

October 25, 2023 — Shockwave Medical, Inc., a pioneer in the development and commercialization of transformational ...

Home October 25, 2023
Home
News | Cath Lab

October 20, 2023 — Over the coming days, Philips will be presenting its latest solutions in cardiology and new late ...

Home October 20, 2023
Home
News | Cath Lab

October 16, 2023 — GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest ...

Home October 16, 2023
Home
News | Cath Lab

October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S ...

Home October 16, 2023
Home
News | Cath Lab

September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...

Home September 13, 2023
Home
News | Cath Lab

August 2, 2023 — Teleflex Incorporated, a leading global provider of medical technologies, announced the U.S Food and ...

Home August 02, 2023
Home
News | Cath Lab

July 13, 2023 — Mount Sinai Queens announced the opening of a new cardiac catheterization lab that will provide rapid ...

Home July 13, 2023
Home
News | Cath Lab

June 21, 2023 — Royal Philips, a global leader in health technology, announced it has teamed up with BIOTRONIK (Lake ...

Home June 21, 2023
Home
Subscribe Now